Spider diagram with greenness evaluation metrics for assessing the new synchronous spectrofluorimetric determination of bicalutamide and resveratrol in human plasma.

bicalutamide greenness plasma resveratrol synchronous fluorescence

Journal

Luminescence : the journal of biological and chemical luminescence
ISSN: 1522-7243
Titre abrégé: Luminescence
Pays: England
ID NLM: 100889025

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 28 07 2023
accepted: 26 08 2023
medline: 5 12 2023
pubmed: 31 8 2023
entrez: 31 8 2023
Statut: ppublish

Résumé

A simple, selective, and eco-friendly synchronous fluorescence approach was introduced for the first time for the concurrent estimation of the anticancer combination therapy of bicalutamide and resveratrol. The method relies on measuring the synchronous fluorescence spectra of bicalutamide and resveratrol at 269 and 320 nm, respectively, using Δλ of 60 nm with ethanol as a green diluting solvent. The procedure was optimized, and the method was then fully validated. Excellent linearity (R

Identifiants

pubmed: 37650746
doi: 10.1002/bio.4586
doi:

Substances chimiques

Resveratrol Q369O8926L
bicalutamide A0Z3NAU9DP
Anilides 0
Ethanol 3K9958V90M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1996-2006

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

C. H. Pernar, E. M. Ebot, K. M. Wilson, L. A. Mucci, Cold Spring Harb. Perspect. Med. 2018, 8, 030361.
P. P. Banerjee, S. Banerjee, T. R. Brown, B. R. Zirkin, Am. J. Clin. Exp. Urol. 2018, 6, 62.
G. Jean-Pierre, DNP, APRN, OCN, J. Adv. Pract. Oncol. 2017, 8, 639.
M. C. Hodgson, I. Astapova, A. N. Hollenberg, S. P. Balk, Cancer Res. 2007, 67, 8388.
I. D. Cockshott, Clin. Pharmacokinet. 2004, 43, 855.
P. F. Schellhammer, Expert Opin. Pharmacother. 2002, 3, 1313.
M. Abbas, F. Saeed, F. M. Anjum, M. Afzaal, T. Tufail, M. S. Bashir, A. Ishtiaq, S. Hussain, H. A. R. Suleria, Int. J. Food Prop. 2017, 20, 1689.
F. Ibrahim, M. K. Sharaf El-Din, R. N. El-Shaheny, A. K. A. K. El-Deen, K. Shimizu, M. K. S. El-Din, R. N. El-Shaheny, A. K. A. K. El-Deen, K. Shimizu, Anal. Methods 2016, 1858, 8.
F. Brisdelli, G. D'Andrea, A. Bozzi, Curr. Drug Metab. 2012, 10, 832.
L. Kai, A. S. Levenson, Anticancer Res. 2011, 31, 3323.
Y. G. Jang, R. E. Go, K. A. Hwang, K. C. Choi, J. Steroid Biochem. Mol. Biol. 2019, 192, 105406.
A. P. N. Majumdar, S. Banerjee, J. Nautiyal, B. B. Patel, V. Patel, J. Du, Y. Yu, A. A. Elliott, E. Levi, F. H. Sarkar, Nutr. Cancer 2009, 61, 544.
C. D. Bernardes, R. J. Poppi, M. M. Sena, Talanta 2010, 82, 640.
D. J. Boocock, K. R. Patel, G. E. S. Faust, D. P. Normolle, T. H. Marczylo, J. A. Crowell, D. E. Brenner, T. D. Booth, A. Gescher, W. P. Steward, J. Chromatogr., B 2007, 848, 182.
M. Nasr, M. H. Abdel Rahman, J. AOAC Int. 2019, 102, 1095.
H. Sahebi, H. Zandavar, S. M. Pourmortazavi, S. Mirsadeghi, J. Chromatogr., B 2021, 1179, 122841.
G. Magdy, A. Saad Radwan, F. Belal, A. Kamal El-Deen, Spectrochim. Acta A Mol. Biomol. Spectrosc. 2023, 302, 123029.
F. Ibrahim, A. K. El-Deen, K. Shimizu, Luminescence 2018, 33, 225.
M. K. Sharaf El-Din, F. Ibrahim, A. K. El-Deen, K. Shimizu, J. Food Drug Anal. 2018, 26, 1160.
G. Magdy, F. Belal, A. M. Abdel-Megied, A. F. Abdel Hakiem, R. Soc. Open Sci. 2021, 8, 210354.
Y.-Q. Li, X.-Y. Li, A. A. F. Shindi, Z.-X. Zou, Q. Liu, L.-R. Lin, N. Li, Rev. Fluoresc. 2012, 2010, 95.
G. Magdy, F. F. Belal, A. M. Abdel-Megied, A. F. Abdel Hakiem, Spectrochim. Acta A. Mol. Biomol. Spectrosc. 2021, 248, 119239.
S. Kumar Panigrahi, A. Kumar Mishra, J. Photochem. Photobiol. C 2019, 41, 100318.
G. Magdy, F. Belal, A. K. El-Deen, Sci. Rep. 2022, 12, 22559.
H. Elmansi, F. Belal, G. Magdy, Sci. Rep. 2022, 12, 9372.
J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Springer, New York, NY 2006.
ICH harmonized tripartite guideline, stability testing of new drug substances and products Q1A (R2), 2003.
S. Kumar, V. Lather, D. Pandita, Food Chem. 2016, 197, 959.
A. K. El-Deen, H. Elmansi, K. Shimizu, Sustain. Chem. Pharm. 2022, 29, 100825.
C. Larsen, P. Lundberg, S. Tang, J. Ràfols-Ribé, A. Sandström, E. Mattias Lindh, J. Wang, L. Edman, Nat. Commun. 2021, 12, 4510.
J. Płotka-Wasylka, Talanta 2018, 181, 204.
F. Pena-Pereira, W. Wojnowski, M. Tobiszewski, Anal. Chem. 2020, 92, 10076.

Auteurs

Asmaa Kamal El-Deen (AK)

Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Aya Saad Radwan (AS)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta, Egypt.

Fathalla Belal (F)

Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

Galal Magdy (G)

Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH